Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

BUY
$0.79 - $22.0 $21,365 - $594,990
27,045 Added 102.29%
53,484 $46,000
Q2 2022

Aug 03, 2022

BUY
$0.8 - $1.5 $2,005 - $3,760
2,507 Added 10.48%
26,439 $22,000
Q1 2022

May 04, 2022

BUY
$1.24 - $2.75 $29,675 - $65,813
23,932 New
23,932 $33,000
Q4 2019

Feb 11, 2020

SELL
$1.25 - $2.57 $16,840 - $34,623
-13,472 Closed
0 $0
Q3 2019

Oct 17, 2019

BUY
$1.26 - $1.96 $16,974 - $26,405
13,472 New
13,472 $19,000

Others Institutions Holding FBIO

About Fortress Biotech, Inc.


  • Ticker FBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,735,000
  • Market Cap $155M
  • Description
  • Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...
More about FBIO
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.